Apellis Pharmaceuticals Inc (APLS) Transcripts
Q2 2024 Apellis Pharmaceuticals Inc Earnings Call Transcript
Aug 01, 2024
$36
(-9.09%)
Earnings
Q1 2024 Apellis Pharmaceuticals Inc Earnings Call Transcript
May 07, 2024
$43.9
(-10.06%)
Earnings
Q4 2023 Apellis Pharmaceuticals Inc Earnings Call Transcript
Feb 27, 2024
$69.35
(-3.32%)
Earnings
Apellis Pharmaceuticals Inc at JPMorgan Healthcare Conference Transcript
Jan 08, 2024
Apellis Pharmaceuticals Inc at Goldman Sachs Healthcare C-Suite Unscripted Conference Transcript
Jan 04, 2024
Apellis Pharmaceuticals Inc to Discuss the CHMP Trend Vote Transcript
Dec 14, 2023
Apellis Pharmaceuticals Inc at Evercore ISI HealthCONx Conference Transcript
Nov 28, 2023
Q3 2023 Apellis Pharmaceuticals Inc Earnings Call Transcript
Nov 01, 2023
$49.9
(+2.55%)
Earnings
Apellis Pharmaceuticals Inc at Robert W Baird Global Healthcare Conference Transcript
Sep 12, 2023
Apellis Pharmaceuticals Inc at Morgan Stanley Global Healthcare Conference Transcript
Sep 11, 2023
Apellis Pharmaceuticals Inc at Wells Fargo Healthcare Conference Transcript
Sep 08, 2023
Apellis Pharmaceuticals Inc at Citi BioPharma Conference Transcript
Sep 06, 2023
Q2 2023 Apellis Pharmaceuticals Inc Earnings Call Transcript
Jul 31, 2023
$25.75
(-19.58%)
Earnings
Apellis Pharmaceuticals Inc at Goldman Sachs Healthcare Conference Transcript
Jun 14, 2023
Apellis Pharmaceuticals Inc at Bank of America Global Healthcare Conference Transcript
May 10, 2023
Q1 2023 Apellis Pharmaceuticals Inc Earnings Call Transcript
May 04, 2023
$84.37
(-0.76%)
Earnings
Apellis Pharmaceuticals Inc SYFOVRE FDA Approval Call Transcript
Feb 17, 2023
Apellis Pharmaceuticals Inc at JPMorgan Healthcare Conference Transcript
Jan 09, 2023
Apellis Pharmaceuticals Inc at Bank of America Biotech SMID Cap Conference Transcript
Dec 07, 2022
Q3 2022 Apellis Pharmaceuticals Inc Earnings Call Transcript
Nov 07, 2022
$47.62
(-5.55%)
Earnings
Apellis Pharmaceuticals Inc at Bank of America Global Healthcare Conference Transcript
Sep 16, 2022
Apellis Pharmaceuticals Inc at Citi BioPharma Conference Transcript
Sep 07, 2022
Apellis Pharmaceuticals Inc Corporate Call Transcript
Aug 24, 2022
Q2 2022 Apellis Pharmaceuticals Inc Earnings Call Transcript
Aug 08, 2022
$62.33
(-1.58%)
Earnings
Apellis Pharmaceuticals Inc at Goldman Sachs Global Healthcare Conference Transcript
Jun 15, 2022
Apellis Pharmaceuticals Inc at Jefferies Healthcare Conference Transcript
Jun 09, 2022
Apellis Pharmaceuticals Inc at Bank of America Healthcare Conference Transcript
May 11, 2022
Q1 2022 Apellis Pharmaceuticals Inc Earnings Call Transcript
May 04, 2022
$45.95
(+3.00%)
Earnings
Apellis Pharmaceuticals Inc at Needham Healthcare Conference (Virtual) Transcript
Apr 11, 2022
Apellis Pharmaceuticals Inc DERBY and OAKS 18 Month Data Conference Call Transcript
Mar 16, 2022
Apellis Pharmaceuticals Inc at Cowen Health Care Conference (Virtual) Transcript
Mar 09, 2022
Q4 2021 Apellis Pharmaceuticals Inc Earnings Call Transcript
Feb 28, 2022
$42.53
Earnings
Apellis Pharmaceuticals Inc at JPMorgan Healthcare Conference (Virtual) Transcript
Jan 10, 2022
Apellis Pharmaceuticals Inc at Credit Suisse Healthcare Conference (Virtual) Transcript
Nov 10, 2021
Q3 2021 Apellis Pharmaceuticals Inc Earnings Call Transcript
Nov 08, 2021
$33.69
(-1.35%)
Earnings
Apellis Pharmaceuticals Inc Announces results from Phase 3Â DERBY and OAKS Transcript
Sep 09, 2021
Q2 2021 Apellis Pharmaceuticals Inc Earnings Call Transcript
Aug 09, 2021
$62
(-2.18%)
Earnings
Apellis Pharmaceuticals Inc Research and Development Day - New York City and Virtually Transcript
Jun 30, 2021
Apellis Pharmaceuticals Inc at Bank of America NAPA Healthcare Conference Transcript
Jun 16, 2021
Apellis Pharmaceuticals Inc at Goldman Sachs Global Healthcare Conference (Virtual) Transcript
Jun 10, 2021
Apellis Pharmaceuticals Inc EMPAVELI FDA Approval Call Transcript
May 17, 2021
Q1 2021 Apellis Pharmaceuticals Inc Earnings Call Transcript
Apr 28, 2021
$45.3
(-0.33%)
Earnings
Q4 2020 Apellis Pharmaceuticals Inc Earnings Call Transcript
Feb 25, 2021
$45.05
(-2.49%)
Earnings
Apellis Pharmaceuticals Inc Virtual Investorm Meeting - Pegcetacoplan: Advancing the First Potential Treatment for Geographic Atrophy (GA) Transcript
Jan 28, 2021
Apellis Pharmaceuticals Inc at JPMorgan Healthcare Conference (Virtual) Transcript
Jan 12, 2021
Apellis Pharmaceuticals Inc Sobi Strategic Collaboration Conference Call Transcript
Oct 27, 2020
Apellis Pharmaceuticals Inc The Evolution of Complement Targeted Therapies Panel at Stifel Immunology & Inflammation Summit (Virtual) Transcript
Oct 01, 2020
Apellis Pharmaceuticals Inc at Citi BioPharma Conference (Virtual) - Fireside Chat Transcript
Sep 10, 2020
Apellis Pharmaceuticals Inc, Aerie Pharmaceuticals, Aldeyra Therapeutics, and ProQR Therapeutic at Citi BioPharma Conference (Virtual) - Panel Transcript
Sep 10, 2020
Apellis Pharmaceuticals Inc to Discuss Phase 3 PEGASUS Study Results - Conference Call Transcript
Jun 12, 2020
Apellis Pharmaceuticals Inc at Goldman Sachs Global Healthcare Conference (Virtual) Transcript
Jun 11, 2020
Apellis Pharmaceuticals Inc at Bank of America Merrill Lynch Healthcare Conference (Virtual) Transcript
May 14, 2020
Apellis Pharmaceuticals Inc at JPMorgan Healthcare Conference Transcript
Jan 14, 2020
Apellis Pharmaceuticals, Inc. - Special Call Transcript
Jan 07, 2020
Apellis Pharmaceuticals Inc at Morgan Stanley Healthcare Conference Transcript
Sep 09, 2019
Editas Medicine Inc, Apellis Pharmaceuticals Inc and Rigel Pharmaceuticals Inc at Citi Biotech Conference Transcript
Sep 05, 2019